705760

Fougera Pharmaceuticals Inc. — FEI 2432435

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 9, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Melville, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)